Ivanova M, Stojkovski I, Klisarovska V. Rapid hyperacute intracranial deterioration following initiation of ipilimumab/nivolumab in BRAF V600E-mutant melanoma of unknown primary with brain metastases after BRAF/MEK inhibitor therapy: a case series. Melanoma Res 2026 Apr 3. doi: 10.1097/CMR.0000000000001098.
PMID: 41941611